Sexually transmitted diseases

AZITHROMYCIN 500 MG 3 TABLETS CHARYN is an antibiotic used to treat various bacterial infections. It requires a prescription. Product Information Brand: Charyn. Manufacturer: Wermar Pharmaceuticals. Active ingredient: Azithromycin dihydrate equivalent to 500 mg of azithromycin. Presentation: Box with 3 tablets. Uses and Indications Azithromycin belongs to a group of antibiotics called macrolides, which work by inhibiting protein synthesis in bacteria to prevent their growth and reproduction. It is used to treat: Respiratory tract infections (sinusitis, pharyngitis, tonsillitis, bronchitis, and pneumonia). Skin and soft tissue infections. Sexually transmitted infections (STIs) such as chlamydia, urethritis, cervicitis, and chancroid. Disseminated Mycobacterium avium complex (MAC) disease in patients with HIV/AIDS. Chronic gastritis and duodenal ulcer caused by Helicobacter pylori.

Samitrogen is an antibiotic containing the active ingredient azithromycin, a macrolide used to treat various bacterial infections. This medication requires a prescription. It is manufactured by Laboratorio Genética. What it is used for Azithromycin is effective against a wide variety of bacteria. Among the infections it can treat are: Respiratory infections such as pneumonia, sinusitis, pharyngitis, and tonsillitis. Sexually transmitted infections such as chlamydia. Skin and soft tissue infections. Ear infections. Side effects The most common side effects of azithromycin, which are usually mild or moderate, include: Gastrointestinal upset: Diarrhea, nausea, vomiting, stomach pain, and abdominal cramps. Headache. Fatigue. Dizziness. More serious, though less common, side effects may include: Liver problems. Severe skin reactions. Heart rhythm disturbances. Important information Not for viral infections: Azithromycin is not effective against viruses, so it should not be used to treat the flu, colds, or most viral sore throats. Complete the treatment: It is essential to complete the full course of treatment prescribed by your doctor, even if your symptoms improve sooner. Stopping treatment prematurely can cause the infection to return and contribute to bacterial resistance. Prescription required: As an antibiotic, it is only available with a valid prescription. Dosage: The 500 mg presentation is common and is often prescribed for short periods, depending on the infection being treated. This content is for informational purposes only. For medical advice or diagnosis, consult a healthcare professional.

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted diseases (STDs).

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted infections (STIs).

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted diseases (STDs). Metronidazole is also used to treat women with bacterial vaginosis (an infection caused by an excess of certain types of harmful bacteria in the vagina). Metronidazole belongs to a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria. Antibiotics are not effective against colds, the flu, or other viral infections. Using antibiotics when not needed increases the risk of developing a future infection that resists antibiotic treatment.

Ciprofloxacin is used to treat or prevent certain infections caused by bacteria such as pneumonia; gonorrhea (a sexually transmitted disease); typhoid fever (a serious infection common in developing countries); infectious diarrhea (infections that cause severe diarrhea); and infections of the skin, bones, joints, abdomen (stomach area), and prostate (male reproductive gland). Ciprofloxacin is also used to treat or prevent plague (a serious infection that may be intentionally spread as part of a bioterrorist attack) and inhalation anthrax (a serious infection that anthrax germs may intentionally spread into the air as part of a bioterrorist attack). Ciprofloxacin can also be used to treat bronchitis, sinus infections, or urinary tract infections, but it should not be used for bronchitis or sinus infections, or for some types of urinary tract infections if other treatment options are available. Ciprofloxacin extended-release (long-acting) tablets are used to treat kidney and urinary tract infections; however, some types of urinary tract infections should only be treated with ciprofloxacin extended-release tablets if no other treatment options are available. Ciprofloxacin belongs to a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections. Antibiotics like ciprofloxacin do not work for colds, influenza, or other viral infections. Using antibiotics when not needed increases the risk of getting an infection later that may resist antibiotic treatment.

Therapeutic Indications Clindamycin Treatment of the following serious infections caused by susceptible microorganisms: in ADs: community-acquired pneumonia caused by Staphylococcus aureus, aspiration pneumonia, empyema (community-acquired), lung abscess, acute pharyngotonsillitis caused by group A streptococcus (S. pyogenes), odontogenic infections, skin and soft tissue infections (complicated and uncomplicated), osteomyelitis, pneumonia caused by Pneumocystis jiroveci (Pneumocystis carinii) in patients with HIV infection, toxoplasmosis encephalitis in patients with HIV infection. In children > 1 month and < 18 years: acute sinusitis. FOSHLENN* is indicated for the treatment of upper respiratory tract infections, such as tonsillitis, pharyngitis, sinusitis, and otitis media, as well as lower respiratory tract infections: bronchitis, pneumonia, empyema, and lung abscess; skin and soft tissue infections; and bone infections.

Therapeutic Indications Clindamycin Treatment of the following serious infections caused by susceptible microorganisms: in ADs: community-acquired pneumonia caused by Staphylococcus aureus, aspiration pneumonia, empyema (community-acquired), lung abscess, acute pharyngotonsillitis caused by group A streptococcus (S. pyogenes), odontogenic infections, skin and soft tissue infections (complicated and uncomplicated), osteomyelitis, pneumonia caused by Pneumocystis jiroveci (Pneumocystis carinii) in patients with HIV infection, toxoplasmosis encephalitis in patients with HIV infection. In children > 1 month and < 18 years: acute sinusitis.

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted diseases (STDs).

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted infections (STIs).

Therapeutic Indications Clarithromycin - Oral, in normal-release and modified-release forms: Adults and children ≥12 years: pharyngitis, tonsillitis, sinusitis (diagnosed), acute bronchitis, acute exacerbation of chronic bronchitis, bacterial pneumonia (community-acquired), mild-to-moderate skin and soft tissue infections, folliculitis, cellulitis, erysipelas. - Oral, in normal-release forms: Adults and children ≥12 years: localized or disseminated M. avium or M. intracellulare infection, localized M. chelonae, M. fortuitum, and M. kansaii infection, gastric or duodenal ulcer associated with H. pylori (with an appropriate antiulcer agent). Prevention of disseminated M. avium complex infection in high-risk HIV patients (CD4 lymphocytes ≤ 50/mm 3 ). Children > 12 months to 11 years: streptococcal pharyngitis, bacterial bronchitis and pneumonia, acute otitis media, impetigo, folliculitis, cellulitis, abscesses. - IV: Adv.: Parenteral treatment for streptococcal pharyngitis or tonsillitis if first-line treatment with beta-lactams is not possible or there is demonstrated sensitivity to S. pyogenes; diagnosed acute bacterial sinusitis; acute exacerbation of chronic bronchitis; mild-moderate skin and soft tissue infections if beta-lactams are not appropriate. It is a macrolide antibiotic with bactericidal action and is effective against a wide range of aerobic and anaerobic bacteria, as well as gram-positive and gram-negative bacteria. It is used for upper and lower respiratory tract infections, skin and soft tissue infections, and infections caused by the Mycobacterium complex (M.

Clarithromycin is useful for the treatment of: Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis, otitis). Lower respiratory tract infections (bronchitis, pneumonia). Therapeutic indications for Clarithromycin: - Oral, in immediate-release and modified-release formulations: Adults and children ≥12 years: pharyngitis, tonsillitis, sinusitis (diagnosed), acute bronchitis, acute exacerbation of chronic bronchitis, bacterial pneumonia (community-acquired), mild-to-moderate skin and soft tissue infections, folliculitis, cellulitis, erysipelas. - Oral, in immediate-release formulations: Adults and children ≥12 years: localized or disseminated infection caused by M. avium or M. intracellulare, localized infection caused by M. chelonae, M. fortuitum, and M. kansaii. Gastric or duodenal ulcer associated with H. pylori (in conjunction with appropriate anti-ulcer medication). Prevention of disseminated M. avium complex infection in high-risk HIV patients (CD4 lymphocytes ≤ 50/mm³). Children > 12 months to 11 years: streptococcal pharyngitis, bacterial bronchitis and pneumonia, acute otitis media, impetigo, folliculitis, cellulitis, abscesses. - IV: Adults: parenteral treatment of streptococcal pharyngitis or tonsillitis if first-line treatment with beta-lactams is not possible or there is demonstrated susceptibility to S. pyogenes; diagnosed acute bacterial sinusitis; acute exacerbation of chronic bronchitis; mild-to-moderate skin and soft tissue infections if beta-lactams are not appropriate.